These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 29323190
1. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. Daly C, Qian X, Castanaro C, Pasnikowski E, Jiang X, Thomson BR, Quaggin SE, Papadopoulos N, Wei Y, Rudge JS, Thurston G, Yancopoulos GD, Davis S. Sci Rep; 2018 Jan 11; 8(1):505. PubMed ID: 29323190 [Abstract] [Full Text] [Related]
2. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface. Hansen TM, Singh H, Tahir TA, Brindle NP. Cell Signal; 2010 Mar 11; 22(3):527-32. PubMed ID: 19922791 [Abstract] [Full Text] [Related]
3. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin. Mosnier LO. J Biol Chem; 2011 Jan 07; 286(1):502-10. PubMed ID: 21041299 [Abstract] [Full Text] [Related]
4. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies. De A, Maulik D, Lankachandra K, Mundy DC, Ye SQ, Gerkovich MM. J Matern Fetal Neonatal Med; 2016 Nov 07; 29(21):3421-8. PubMed ID: 26752164 [Abstract] [Full Text] [Related]
5. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, Ahn SY, Kim HZ, Lee GM, Koh GY. J Biol Chem; 2005 May 20; 280(20):20126-31. PubMed ID: 15769741 [Abstract] [Full Text] [Related]
6. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells. Wu C, Kim PY, Swystun LL, Liaw PC, Weitz JI. J Thromb Haemost; 2016 Feb 20; 14(2):366-74. PubMed ID: 26663133 [Abstract] [Full Text] [Related]
7. Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap. Bate N, Lodge J, Brindle NPJ. J Biol Chem; 2021 Aug 20; 297(2):100888. PubMed ID: 34153320 [Abstract] [Full Text] [Related]
8. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin. Marar TT, Boffa MB. J Thromb Haemost; 2016 Apr 20; 14(4):772-83. PubMed ID: 26816270 [Abstract] [Full Text] [Related]
9. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis. Kim HZ, Jung K, Kim HM, Cheng Y, Koh GY. Biochim Biophys Acta; 2009 May 20; 1793(5):772-80. PubMed ID: 19339208 [Abstract] [Full Text] [Related]
11. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells. Prevete N, Staiano RI, Granata F, Detoraki A, Necchi V, Ricci V, Triggiani M, De Paulis A, Marone G, Genovese A. J Biol Regul Homeost Agents; 2013 Jan 30; 27(3):827-39. PubMed ID: 24152847 [Abstract] [Full Text] [Related]
12. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow. van Moorsel MVA, Poolen GC, Koekman CA, Verhoef S, de Maat S, Barendrecht A, van Kleef ND, Meijers JCM, Schiffelers RM, Maas C, Urbanus RT. J Thromb Haemost; 2022 May 30; 20(5):1213-1222. PubMed ID: 35170225 [Abstract] [Full Text] [Related]
13. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF. Saito M, Watanabe J, Fujisawa T, Kamata Y, Nishimura Y, Arai T, Miyamoto T, Obokata A, Kuramoto H. Eur J Gynaecol Oncol; 2006 May 30; 27(2):129-34. PubMed ID: 16620053 [Abstract] [Full Text] [Related]
14. The impact of the endothelial protein C receptor on thrombin generation and clot lysis. Pepler L, Wu C, Dwivedi DJ, Wu C, Kim PY, Liaw PC. Thromb Res; 2017 Apr 30; 152():30-37. PubMed ID: 28219843 [Abstract] [Full Text] [Related]
15. Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling. Ikezoe T, Yang J, Nishioka C, Honda G, Furihata M, Yokoyama A. Arterioscler Thromb Vasc Biol; 2012 Sep 30; 32(9):2259-70. PubMed ID: 22796578 [Abstract] [Full Text] [Related]
16. Angiopoietins are expressed in the normal rat pituitary gland. Nag S, Nourhaghighi N, Venugopalan R, Asa SL, Stewart DJ. Endocr Pathol; 2005 Sep 30; 16(1):67-73. PubMed ID: 16000849 [Abstract] [Full Text] [Related]
17. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses. Pietilä R, Nätynki M, Tammela T, Kangas J, Pulkki KH, Limaye N, Vikkula M, Koh GY, Saharinen P, Alitalo K, Eklund L. J Cell Sci; 2012 May 01; 125(Pt 9):2212-23. PubMed ID: 22357955 [Abstract] [Full Text] [Related]
18. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. Bajzar L, Nesheim M, Morser J, Tracy PB. J Biol Chem; 1998 Jan 30; 273(5):2792-8. PubMed ID: 9446587 [Abstract] [Full Text] [Related]
19. Synthesis of Human Neutrophil Extracellular Traps Contributes to Angiopoietin-Mediated In Vitro Proinflammatory and Proangiogenic Activities. Lavoie SS, Dumas E, Vulesevic B, Neagoe PE, White M, Sirois MG. J Immunol; 2018 Jun 01; 200(11):3801-3813. PubMed ID: 29686052 [Abstract] [Full Text] [Related]